By Finance Pulse in Transformative —

Moderna Leads S&P 500 with Bird Flu Vaccine Hopes

Moderna's stock tops S&P 500, fueled by optimism around its experimental bird flu vaccine. Explore why investors are excited about this potential breakthrough.

A stylized graphic of a soaring upward stock chart with a background featuring a scientific illustra
Moderna Leads S&P 500 with Bird Flu Vaccine Hopes

Moderna was the best-performing stock in the S&P 500, driven by expectations for its experimental bird flu vaccine.

Source